Gerrit Steen
Directeur Général chez Fresenius HemoCare Beteiligungs GmbH
Profil
Gerrit Steen is currently the Director at Fresenius Kabi Pharmaceuticals Holding LLC, Co-Managing Director at Fresenius HemoCare Beteiligungs GmbH, and Chief Financial Officer at Fresenius Kabi AG.
He previously worked as a Non-Executive Director at Fresenius Kabi Oncology Ltd.
Mr. Steen received an MBA from WHU-Otto Beisheim School of Management.
Postes actifs de Gerrit Steen
| Sociétés | Poste | Début |
|---|---|---|
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Directeur Financier/CFO | 12/01/2010 |
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | 01/03/2011 |
Fresenius HemoCare Beteiligungs GmbH
 Fresenius HemoCare Beteiligungs GmbH Financial ConglomeratesFinance Part of Fresenius SE & Co. KGaA, Fresenius HemoCare Beteiligungs GmbH is a German company that provides investment services. The company is based in Bad Homburg vd Höhe, Germany. The CEOs of the company are Gerrit Steen, Mats Christer Henriksson. | Directeur Général | - |
Anciens postes connus de Gerrit Steen
| Sociétés | Poste | Fin |
|---|---|---|
| FRESENIUS KABI ONCOLOGY LTD | Directeur/Membre du Conseil | - |
Formation de Gerrit Steen
| WHU-Otto Beisheim School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Fresenius Kabi Oncology Ltd.
 Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Fresenius Kabi Oncology Ltd. is a research and development company, which engages in manufacturing and development of oncology drugs. It also develops active pharmaceutical ingredients, intermediates and oral and injectable finished dosage forms. The company was founded on March 18, 2003 and is headquartered in Gurgaon, India. | Commercial Services |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
Fresenius HemoCare Beteiligungs GmbH
Fresenius HemoCare Beteiligungs GmbH Financial ConglomeratesFinance Part of Fresenius SE & Co. KGaA, Fresenius HemoCare Beteiligungs GmbH is a German company that provides investment services. The company is based in Bad Homburg vd Höhe, Germany. The CEOs of the company are Gerrit Steen, Mats Christer Henriksson. | Finance |
